The firm has admitted it essentially disabled Secure Boot on its motherboards in an attempt to improve customisability
Source: www.itpro.co.uk and Read More

Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing
Pfizer unveiled a multi-drug R&D collaboration with Innovent Biologics, making it the latest big pharma company to reach a deal that taps into Chinese labs


